Literature DB >> 8734826

Differences between black and white patients with cancer of the uterine corpus in interval from symptom recognition to initial medical consultation (United States).

R J Coates1, L A Click, L C Harlan, S Robboy, R J Barrett, J W Eley, P Reynolds, V W Chen, W A Darity, R S Blacklow, B K Edwards.   

Abstract

To determine whether Black women with symptoms of uterine corpus cancer had longer times from symptom recognition to initial medical consultation than did White women in the United States, 331 newly diagnosed patients living in Atlanta (GA), New Orleans (LA), and San Francisco/Oakland (CA) during 1985-87 were interviewed to collect information on symptoms, dates of recognition and consultation, and other factors that might affect the interval. Data were analyzed to estimate medical consultation rates and rate ratios following symptom recognition. Median recalled times between symptom recognition and consultation were 16 days for Black women and 14 days for White women. Although poverty, having no usual source of healthcare, and other factors were associated with lower consultation rates, the adjusted rate among Black women was only somewhat lower (0.87) than among White women, and the 95 percent confidence interval (CI = 0.58-1.31) was consistent with no true difference between the races. In addition, the median time to consultation for women with stage IV cancer was only 15 days longer than the time (14 days) for the women with stage I cancer. These results suggest that time from symptom recognition to initial medical consultation does not contribute importantly to the more advanced stage cancer of the uterine corpus commonly found among Black women.

Entities:  

Mesh:

Year:  1996        PMID: 8734826     DOI: 10.1007/bf00052938

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  26 in total

1.  Delay in seeking care for cancer symptoms: a population-based study of elderly New Mexicans.

Authors:  J M Samet; W C Hunt; M L Lerchen; J S Goodwin
Journal:  J Natl Cancer Inst       Date:  1988-05-18       Impact factor: 13.506

2.  Delay in breast cancer and the nature of presenting symptoms.

Authors:  C MacArthur; A Smith
Journal:  Lancet       Date:  1981-03-14       Impact factor: 79.321

3.  Simulation study of confounder-selection strategies.

Authors:  G Maldonado; S Greenland
Journal:  Am J Epidemiol       Date:  1993-12-01       Impact factor: 4.897

4.  Black Americans' attitudes toward cancer and cancer tests: highlights of a study.

Authors: 
Journal:  CA Cancer J Clin       Date:  1981 Jul-Aug       Impact factor: 508.702

5.  The relationship of delay in treatment to prognosis in human cancer.

Authors:  B Gardner
Journal:  Prog Clin Cancer       Date:  1978

6.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

7.  Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group.

Authors:  R J Coates; D D Bransfield; M Wesley; B Hankey; J W Eley; R S Greenberg; D Flanders; C P Hunter; B K Edwards; M Forman
Journal:  J Natl Cancer Inst       Date:  1992-06-17       Impact factor: 13.506

8.  Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer.

Authors:  S W Vernon; B C Tilley; A V Neale; L Steinfeldt
Journal:  Cancer       Date:  1985-04-01       Impact factor: 6.860

9.  Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay.

Authors:  N C Facione
Journal:  Soc Sci Med       Date:  1993-06       Impact factor: 4.634

10.  Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year.

Authors:  J L Richardson; B Langholz; L Bernstein; C Burciaga; K Danley; R K Ross
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

View more
  5 in total

1.  Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival.

Authors:  Terri Madison; David Schottenfeld; Sherman A James; Ann G Schwartz; Stephen B Gruber
Journal:  Am J Public Health       Date:  2004-12       Impact factor: 9.308

2.  The Impact of Fibroids and Histologic Subtype on the Performance of US Clinical Guidelines for the Diagnosis of Endometrial Cancer among Black Women.

Authors:  Sarah S Romano; Kemi M Doll
Journal:  Ethn Dis       Date:  2020-09-24       Impact factor: 1.847

3.  The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Rodney P Rocconi; Heather A Lankes; William E Brady; Paul J Goodfellow; Nilsa C Ramirez; Ronald D Alvarez; William Creasman; José R Fernández
Journal:  Gynecol Oncol       Date:  2015-11-18       Impact factor: 5.482

4.  Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers.

Authors:  U Macleod; E D Mitchell; C Burgess; S Macdonald; A J Ramirez
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

5.  Assessment of Prediagnostic Experiences of Black Women With Endometrial Cancer in the United States.

Authors:  Kemi M Doll; Bridgette Hempstead; Julianna Alson; Liz Sage; Danielle Lavallee
Journal:  JAMA Netw Open       Date:  2020-05-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.